JOURNAL OF CHILEAN CHEMICAL SOCIETY

Vol 65 No 2 (2020): Journal of the Chilean Chemical Society
Original Research Papers

THEORETICAL INVESTIGATION OF THE MOLECULAR STRUCTURE AND MOLECULAR DOCKING OF ETORICOXIB

PDF
  • Luis Humberto Mendoza-Huizar,
  • Dr. Kandasamy,
  • Dr. Salgado,
  • Dr. Cardona,
  • Dr. Gerli ,
  • Dr. Lorena ,
  • Dr. Cuesta
Luis Humberto Mendoza-Huizar
Universidad Autónoma del Estado de Hidalgo
Dr. Kandasamy
Bannari Amman Institute of Technology
Dr. Salgado
Universidad de Chile
Dr. Cardona
Universidad Andrés Bello
Dr. Gerli
Universidad Católica de la Santísima Concepción
Published July 18, 2020
Keywords
  • etoricoxib,
  • activity,
  • DFT,
  • COX-2,
  • docking
How to Cite
Mendoza-Huizar, L. H., Sadasivam, K., Salgado Moran, G., Cardona Villada, W., Gerli Candia, L., Meneses-Olmedo, L. M., & Cuesta Hoyos, S. (2020). THEORETICAL INVESTIGATION OF THE MOLECULAR STRUCTURE AND MOLECULAR DOCKING OF ETORICOXIB. Journal of the Chilean Chemical Society, 65(2), 4804-4806. Retrieved from https://jcchems.com/index.php/JCCHEMS/article/view/1357

Copyright (c) 2020 Journal of the Chilean Chemical Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Abstract

In this work, a computational chemical study of Etoricoxib was carried out at the B3LYP/6311G(d,p) level of theory, at the gas, aqueous and ethanol phases. Through the chemical reactivity descriptors derived from the DFT, it was possible to find that Etoricoxib structure exhibits a major chemical activity in water and ethanol phases in comparison to the gas phase, which suggests this drug would be more active in biological solvents like in blood, tissues and places where the ciclooxigenasa 2 (COX)-2 is found. In addition, a molecular docking analysis was conducted to study the interaction of Etoricoxib with the COX-2 active site. The results suggest that Etoricoxib interacts with 19 amino acid residues inside the COX-2 active site.

 

1357.jpg

PDF

References

  1. Y. Chai, L. Wang, Y. Bao, R. Teng, Y. Liu, C. Xie, Cryst. Growth Des. 19, 1660, (2019)
  2. A. Okumu, M. DiMaso, R. Löbenberg, Eur. J. Pharm. Biopharm. 72(1), 91, (2009)
  3. M. Palucki, Z. Lin, Y. Sun, Org. Process Res. Dev. 9(2), 141, (2005)
  4. M. Rams-Baron, J. Pacult, A. Jedrzejowska, J. Knapik-Kowalczuk, M. Paluch, Mol. Pharm., 15(9), 3969, (2018)
  5. H. S. Omer Erkan Yapca, Mehmet Ibrahim Turan, Ismayil Yilmaz, Suleyman Salman, Mine Gulapoglu, J. Obstet. Gynaecol. Res. 40(6), 1674, (2014)
  6. M. Rams-Baron, Z. Wojnarowska, K. Grzybowska, M. Dulski, J. Knapik, K. Jurkiewicz, W. Smolka, W. Sawicki, A. Ratuszna, M. Paluch, Mol. Pharm. 12(10), 3628, (2015)
  7. T. Zhang, L. Wang, Y. Bao, Q. Yang, L. Zhou, H. Hao, C. Xie, J. Pharm. Sci. 107(7), 1903, (2018)
  8. P. Grobelny, A. Mukherjee, G. R. Desiraju, CrystEngComm. 14, 5785, (2012)
  9. C. Rodríguez-Tinoco, M. Rams-Baron, K. L. Ngai, K. Jurkiewicz, J. Rodríguez-Viejo, M. Paluch, Phys. Chem. Chem. Phys. 20, 3939, (2018)
  10. N. G. B. Agrawal, A. G. Porras, C. Z. Matthews, M. J. Rose, E. J. Woolf, B. J. Musser, A. L. Dynder, K. E. Mazina, K. C. Lasseter, T. L. Hunt, et al., J. Clin. Pharmacol. 43(3), 268, (2003)
  11. S. Oniga, L. Pacureanu, C. Stoica, M. Palage, A. Crăciun, L. Rusu, E.-L. Crisan, C. Araniciu, Molecules 22(9), 1507, (2017)
  12. S. Sil, T. Ghosh, J. Neuroimmunol. 317, 15, (2018)
  13. T. Yapanoglu, F. Ozkaya, A. H. Yilmaz, R. Mammadov, F. K. Cimen, E. Hirik, Korean J. Physiol. Pharmacol. 21(5), 457, (2017)
  14. A. Maheshwari, L. Badgujar, B. Phukan, S. L. Bodhankar, P. Thakurdesai, Eur. J. Pharmacol. 667(1-3), 230, (2011)
  15. K. Anbazhakan, K. Sadasivam, R. Praveena, Struct. Chem. 30(4), 1, (2019)
  16. M. Leopoldini, T. Marino, N. Russo, M. Toscano, J. Phys. Chem. A. 108(2), 4916, (2004)
  17. R. Praveena, K. Sadasivam, V. Deepha, R. Sivakumar, J. Mol. Struct. 1061(5), 114, (2014)
  18. M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, et al., (2009)
  19. P. Geerlings, F. De Proft, W. Langenaeker, Chem. Rev. 103(5), 1793, (2003)
  20. R. G. Parr, W. Yang, Density-Functional Theory of Atoms and Molecules, First ed., Oxford University Press, New York, 1989.
  21. R. G. Parr, R. G. Pearson, J. Am. Chem. Soc. 105(26), 7512, (1983)
  22. R. G. Pearson, J. Chem. Educ. 64(7), 561, (1987)
  23. R. G. Parr, P. K. Chattaraj, J. Am. Chem. Soc. 113(5), 1854, (1991)
  24. R. G. Pearson, J. Am. Chem. Soc. 107(24), 6801, (1985)
  25. PyMOL, The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC.
  26. E. F. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, T. E. Ferrin, J. Comput. Chem. 25(13), 1605, (2004)
  27. C. Steffen, K. Thomas, U. Huniar, A. Hellweg, O. Rubner, A. Schroer, J. Comput. Chem. 31(16), 2967, (2010)
  28. D. S. Wishart, Y. D. Feunang, A. C. Guo, E. J. Lo, A. Marcu, J. R. Grant, T. Sajed, D. Johnson, C. Li, Z. Sayeeda, et al., Nucleic Acids Res. 46(D1), D1074, (2018)
  29. A. J. O. Oleg Trott, A. Schroer, J. Comput. Chem. 31(2), 455, (2010)
  30. R. A. Laskowski, M. B. Swindells, J. Chem. Inf. Model. 51(10), 2778, (2011)
  31. D. L. DeWitt, Mol. Pharmacol. 55(4), 625, (1999)
  32. A. L. Blobaum, L. J. Marnett, J. Med. Chem. 50(7), 1425, (2007)
  33. R. Ferreira De Freitas, M. Schapira, Medchemcomm. 8, 1970, (2017)
  34. J. L. Medina-Franco, O. Méndez-Lucio, K. Martinez-Mayorga, Adv. Protein Chem. Struct. Biol. 96, 1, (2014)
  35. J. E. Donald, D. W. Kulp, W. F. DeGrado, Proteins Struct. Funct. Bioinforma. 79(3), 898, (2011)
  36. L. Yang, J. Zhang, X. Che, Y. Q. Gao, Methods Enzymol. 578, 169, (2016)

Copyright @2019 | Designed by: Open Journal Systems Chile Logo Open Journal Systems Chile Support OJS, training, DOI, Indexing, Hosting OJS

Code under GNU license: OJS PKP